A new RP-HPLC approach for estimation of potential impurities of Fosamprenavir - method development and validation

Thumbnail Image

Files

A_new_RP-HPLC_approach_for_estimation_of_potential_impurities_of_Fosamprenavir_-_method_development_and_validation.pdf (2.58 MB)

Access rights

openAccess
CC BY-NC-ND
publishedVersion

URL

Journal Title

Journal ISSN

Volume Title

A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä
This publication is imported from Aalto University research portal.
View publication in the Research portal (opens in new window)
View/Open full text file from the Research portal (opens in new window)
Unless otherwise stated, all rights belong to the author. You may download, display and print this publication for Your own personal use. Commercial use is prohibited.

Authors

Date

2025-12

Department

Department of Applied Physics

Major/Subject

Mcode

Degree programme

Language

en

Pages

9

Series

BMC Pharmacology and Toxicology, Volume 26, issue 1, pp. 1-9

Abstract

The current work aims to develop a reliable and robust RP-HPLC method for analyzing Fosamprenavir and its potential impurities, including isomer, amino, propyl, nitro, and Amprenavir. The method used a Zobrax C18 column with a mobile phase of 0.1% V/V orthophosphoric acid in water and acetonitrile in gradient elution at a flow rate of 1 mL/min to accomplish efficient separation with detection at 264 nm and column temperature of 30 ± 20C. A diluent with a 1:1 water-to-acetonitrile ratio was used to prepare standard and sample solutions. The developed approach was validated as per ICH Q2(R1) guidelines. Fosamprenavir, Amino, Propyl, Isomer, Nitro impurities, and Amprenavir impurities were eluted at retention time (RT) of 5.3 min, 2.3 min, 4.3 min, 4.7 min, 8.1 min and 8.6 min correspondingly with good resolution within a 10-minute run time. Method validation confirmed system suitability, linearity (R² = 0.999), good sensitivity (LOD/LOQ), specificity, precision (% RSD: 0.5–1.7), accuracy (% recovery: 90.9-104.3%), and robustness. The optimized approach excelled existing methods in lower retention time, run time, sensitivity, and linearity for all potential impurities, making it a novel and trustworthy method for monitoring Fosamprenavir drug quality and assessing stated impurities. The established method allows precise measurement of Fosamprenavir and related substances, supporting drug safety and regulatory compliance.

Description

Publisher Copyright: © The Author(s) 2025.

Keywords

Fosamprenavir, Gradient elution, Linearity, Potential impurities, Sensitivity

Other note

DOI

10.1186/s40360-025-00892-5

Citation

Godela, R, Nelson, V K, Nuli, M V, Jaini, P K, Pathak, S, Ponnekanti, K, Suryadevara, P R, Burle, G S, Mayasa, V & Kesari, K K 2025, 'A new RP-HPLC approach for estimation of potential impurities of Fosamprenavir - method development and validation', BMC Pharmacology and Toxicology, vol. 26, no. 1, 60, pp. 1-9. https://doi.org/10.1186/s40360-025-00892-5

Permanent link to this item

https://urn.fi/URN:NBN:fi:aalto-202504093115

Collections

[article-cris] Perustieteiden korkeakoulu / SCI